Original articleGeneral thoracicMultidisciplinary Management of Life-Threatening Massive Hemoptysis: A 10-Year Experience
Section snippets
Selection of Patients and Management
From January 1995 to December 2005, 120 patients (93 males; mean age, 60.3 years; range, 16 to 89 years) were admitted to our emergency center with life-threatening massive hemoptysis. At our institution, life-threatening massive hemoptysis is defined as the expectoration of 600 mL or more of blood over the course of 24 hours, and all patients included in this study satisfied that criterion. To compare the contemporary outcomes with previous years, the patients were divided into two groups
Characteristics of Patients Who Underwent Bronchial Artery Embolization and Outcomes From 2000 to 2005
Of the 120 patients who were admitted to our center with life-threatening massive hemoptysis between January of 1995 and December of 2005, the recent group (2000 to 2005) had 71 patients. Of the 71 patients in whom conservative treatment failed, 62 (52 males, 10 females; mean age, 58.4 years; range, 32 to 89 years) underwent a bronchial arteriography examination, which showed that the cause of the massive hemoptysis was old tuberculosis in 34, bronchiectasis in 14, mycetoma in 5, lung cancer in
Comment
The recent emergence of BAE as a therapeutic modality for life-threatening massive hemoptysis has revolutionized management of the disease, as it is a less invasive but reliable procedure that leads to excellent therapeutic outcomes [6, 7, 8]. Nevertheless, surgical management of massive hemoptysis still plays an important role as a therapeutic strategy. A number of studies have addressed the management of massive hemoptysis by focusing on a single treatment modality, such as BAE or pulmonary
References (16)
- et al.
Percutaneous embolotherapy for life-threatening hemoptysis
Chest
(2002) - et al.
Managing life-threatening hemoptysis: has anything really changed?
Chest
(2000) - et al.
Superselective bronchial artery embolization for hemoptysis with a coaxial microcatheter system
J Vasc Interv Radiol
(1997) - et al.
Bronchial artery embolization: experience with 54 patients
Chest
(2002) - et al.
Management and prognosis of massive hemoptysisRecent experiences with 120 patients
J Thorac Cardiovasc Surg
(1993) Clinical assessment and management of massive hemoptysis
Crit Care Med
(2000)- et al.
The pulmonary physician in critical care
Thorax
(2003) Pulmonary resection for massive hemoptysis of benign etiology
(2003)
Cited by (94)
Evaluation and Treatment of Massive Hemoptysis
2022, Surgical Clinics of North AmericaCitation Excerpt :The investigators also noted that both emergency surgery and pneumonectomy independently predicted complications including mortality.70 Ideally, every effort should be made to control bleeding before surgery, as both mortality and morbidity increase with emergent surgical resection.70–72 However, there are still circumstances where surgery is indicated for first-line therapy including pulmonary artery rupture, complex arteriovenous malformations, or refractory hemoptysis in the setting of benign lung disease and chest wall trauma.73–75
Lung Cancer Emergencies
2018, IASLC Thoracic OncologyIs VATS suitable for lung diseases with hemoptysis? Experience from a hemoptysis treatment center in China
2023, BMC Pulmonary MedicineHemoptysis in Cancer Patients
2023, CancersBronchial Artery Embolization Procedure for Treatment of Hemoptysis Caused by Cavitary Lung Lesions
2023, The Egyptian Journal of Hospital MedicineBronchial Artery Embolization Procedure for Treatment of Hemoptysis Caused by Cavitary Lung Lesions
2023, The Egyptian Journal of Hospital Medicine